tolvaptan has been researched along with natriuretic peptide, brain in 14 studies
| Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 967 | 172 | 786 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | tolvaptan (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, GS; Unzek, S | 1 |
| Boerrigter, G; Burnett, JC; Cataliotti, A; Costello-Boerrigter, LC; Harty, GJ | 1 |
| Gheorghiade, M; Konstam, MA; Pang, PS | 1 |
| Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M | 1 |
| Ambrosy, AP; Butler, J; Gheorghiade, M; Greene, SJ; Vaduganathan, M | 1 |
| Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K | 1 |
| Bart, BA; Burnett, J; Goldsmith, SR | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
| Dohi, K; Fujimoto, N; Ito, M; Kumagai, N; Nakamori, S; Ogura, T; Sato, Y; Sugimoto, T; Sugiura, E; Takeuchi, T; Tanimura, M; Watanabe, K; Yamada, N | 1 |
| Griffin, M; Konstam, MA; McCallum, W; Sarnak, MJ; Testani, JM; Tighiouart, H; Udelson, JE | 1 |
| Mori, T; Shinoda, R; Shinoda, Y; Yoshimura, T | 1 |
| Chino, S; Endo, Y; Fukuoka, H; Hachiya, R; Ichikawa, S; Kuroki, Y; Miyazaki, H; Mochizuki, Y; Omomo, Y; Ota, M; Shibakai, M; Shinke, T; Toyosaki, E | 1 |
| Kawano, M; Nakano, M; Nishio, S; Tajima, E; Takimura, H; Takimura, Y; Taniguchi, R; Tsukahara, R; Tsuzuki, I; Yamaguchi, Y | 1 |
| Guo, M; Hao, M; Yang, J; Zhang, L | 1 |
3 review(s) available for tolvaptan and natriuretic peptide, brain
| Article | Year |
|---|---|
Management of heart failure: a brief review and selected update.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Diuretics; Heart Failure; Hemofiltration; Humans; Hydrazones; Natriuretic Peptide, Brain; Pacemaker, Artificial; Pyridazines; Simendan; Tolvaptan; Vasodilator Agents | 2008 |
The disconnect between phase II and phase III trials of drugs for heart failure.
Topics: Animals; Benzazepines; Cardiovascular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Patient Readmission; Patient Selection; Pyridazines; Pyridines; Risk Assessment; Risk Factors; Simendan; Tetrazoles; Time Factors; Tolvaptan; Treatment Outcome; Xanthines | 2013 |
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
2 trial(s) available for tolvaptan and natriuretic peptide, brain
| Article | Year |
|---|---|
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Japan; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Research Design; Tolvaptan | 2014 |
Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure.
Topics: Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Biomarkers; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Stroke Volume; Tolvaptan | 2020 |
9 other study(ies) available for tolvaptan and natriuretic peptide, brain
| Article | Year |
|---|---|
Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.
Topics: Aldosterone; Animals; Benzazepines; Blood Pressure; Disease Models, Animal; Dogs; Drug Therapy, Combination; Glomerular Filtration Rate; Heart Failure; Male; Natriuretic Agents; Natriuretic Peptide, Brain; Receptors, Vasopressin; Renal Circulation; Tolvaptan; Water-Electrolyte Balance | 2010 |
Seeking new heights in acute heart failure syndromes: lessons from ASCEND and EVEREST.
Topics: Acute Disease; Benzazepines; Drug Approval; Heart Failure; Humans; Natriuretic Peptide, Brain; Randomized Controlled Trials as Topic; Syndrome; Tolvaptan; Treatment Outcome; Vasodilator Agents | 2013 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypernatremia; Kidney Function Tests; Male; Multivariate Analysis; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Time Factors; Tolvaptan; Urination | 2013 |
Decongestive therapy and renal function in acute heart failure: time for a new approach?
Topics: Acute Disease; Benzazepines; Dopamine; Heart Failure; Humans; Kidney; Natriuretic Peptide, Brain; Tolvaptan; Ultrafiltration | 2014 |
Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Creatinine; Diuresis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Natriuretic Peptide, Brain; Prognosis; Retrospective Studies; Sodium; Tolvaptan; Ventricular Pressure | 2016 |
[Retrospective Observational Study on Predictors of Body Weight and BNP Teduction in Cases of Tolvaptan Induction for Heart Failure].
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Body Weight; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Retrospective Studies; ROC Curve; Sodium; Tolvaptan | 2021 |
Right ventricular contractility affects the clinical efficacy of add-on tolvaptan following hospitalization for heart failure in patients with significant tricuspid regurgitation.
Topics: Aged; Aged, 80 and over; Heart Failure; Hospitalization; Humans; Middle Aged; Natriuretic Peptide, Brain; Stroke Volume; Tolvaptan; Treatment Outcome; Tricuspid Valve Insufficiency; Ventricular Function, Left | 2022 |
Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
Topics: Acute Disease; Diuretics; Heart Failure; Hospital Mortality; Humans; Natriuretic Peptide, Brain; Retrospective Studies; Tolvaptan | 2023 |
Effects of recombinant human brain natriuretic peptide combined with tolvaptan on cardiac and renal function and serum inflammatory factors in patients with severe heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Kidney; Natriuretic Peptide, Brain; Retrospective Studies; Tolvaptan | 2023 |